These kinases are downstream targets of functional pre‐BCR (B‐cell receptor), a distinctive feature of human TCF3‐PBX1 leukemia, and two of its main targets after pre‐BCR stimulation are CrkL and PLCg2 [46, 47]. The gene discussed is PLCG2; the disease is leukemia.